GLICADAY 30 MR

MRP

91/Strip

Description

• Each Uncoated Modified Release Tablet Containes: Gliclazide IP 30 mg

Doses

• As Directed by Physician

Indication

• Gliclazide is one of a group of medicines called sulfonylureas that are used to lower the blood  sugar level. Gliclazide tablets are used to treat maturity onset diabetes in patients that is not controlled by diet alone. They are not for use in children or in patients with diabetes requiring insulin.